过去一年中添加的文章，按日期排序
… dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A systematic review and meta‐analysis
31 天前 - … 3, randomized controlled trial (RCT)—found no significant difference in progression-free
survival (PFS) between previously-untreated patients … ) versus bortezomib/lenalidomide/…
survival (PFS) between previously-untreated patients … ) versus bortezomib/lenalidomide/…